"EO 14398" five (5) genomic sequencing systems miseq I100 plus systems
Active Purchase Order Awarded
- Contract number
- 75F40126P00203
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $574,785
Award facts
- Opportunity
-
- Four (4) each Genomic Sequencing Systems Solicitation · RFQFDA133845133915 · Posted Jun 15, 2026
- Contract value 66% obligated
-
- $574,784.84 Current, with exercised options
- $871,490.84 Potential, with all options
- Completion date 2% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Laurel, MD 20707, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
About this award
The Food and Drug Administration issued a purchase order to Illumina, Inc. on September 17, 2026 for five Illumina MiSeq i100 Plus genomic sequencing systems, with a ceiling value of $871,490.84 and ultimate completion by November 16, 2030.
Place of performance is Laurel, MD. The systems are procured under Executive Order 14398 to support whole genome sequencing for bacterial and viral organisms. Each unit includes touchscreen monitor, embedded control software, pre-installed DRAGEN Bio-IT secondary analysis pipeline, initial reagent kits, and 12-month manufacturer warranty. The solicitation, posted June 15, 2026 with offers due June 26, 2026, specified delivery within six weeks of award with on-site installation by certified Illumina personnel and hands-on training for FDA staff. The procurement was conducted on a brand-name or equal basis restricted to the MiSeq i100 Plus and DRAGEN Bio-IT Platform to maintain continuity with existing FDA sequencing infrastructure. Optional four-year maintenance agreements covering preventative maintenance, parts, labor, and consumables are available post-warranty.
Quick answers
Who was awarded contract 75F40126P00203?
75F40126P00203 was awarded to Illumina, Inc. by Food and Drug Administration (Department of Health and Human Services) on September 17, 2026.
How much is contract 75F40126P00203 worth?
The government has obligated $574,785 on 75F40126P00203. Its potential value, with all options, is $871,491.
Was contract 75F40126P00203 competed?
The extent of competition for 75F40126P00203 was competed under sap. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award